Reverse left ventricular (LV) remodeling and recovery of LV function are associated with
improved clinical outcomes in patients with heart failure with reduced ejection fraction. A …

Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Acute decompensated heart failure (ADHF) is one of the leading admission diagnoses
worldwide, yet it is an entity with incompletely understood pathophysiology and limited …

Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost,
morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis …

Objectives: The aim of this study was to determine if individual or multiple biomarkers are
associated with cardiotoxicity in patients with breast cancer undergoing cancer therapy …

The purpose of this focused update is to update the “2013 ACCF/AHA Guideline for the
Management of Heart Failure” 9 (2013 HF guideline) in areas in which new evidence has …

Background—Oxidative stress may contribute to heart failure (HF) progression. Inhibiting
xanthine oxidase in hyperuricemic HF patients may improve outcomes. Methods and …

Background—We hypothesized that patients with heart failure (HF) who recover left
ventricular function (HF-Recovered) have a distinct clinical phenotype, biology, and …

Objectives: This analysis aimed to perform a head-to-head comparison of 3 of the promising
biomarkers of cardiovascular (CV) outcomes in heart failure (HF)—soluble ST2 (sST2) …